Peter Maccallum Cancer Centre

Parkville, Victoria 3052

2 studies enrolling now · 6 studies all time

What they study most

Advanced MTAP-null Solid Tumors, KRAS p.G12C Mutant Advanced Solid Tumors, Metastatic Castration-resistant Prostate Cancer, Newly Diagnosed Glioblastoma, PD-L1 Positive, Prostate Cancer, Solid Tumor, Triple Negative Breast Cancer

Studies at this site

• Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab — Recruiting now
• A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors — Recruiting now
• A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100) — Completed
• A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101) — Running, not enrolling
• Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC — Stopped early
• Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer — Running, not enrolling